1-8 of 8
David E. Spaner
Close
Sort by
Journal Articles

High-content screening identifies kinase inhibitors that overcome venetoclax resistance in activated CLL cells

Sina Oppermann, Jarkko Ylanko, Yonghong Shi, Santosh Hariharan, Christopher C. Oakes, Patrick M. Brauer, Juan C. Zúñiga-Pflücker, Brian Leber, David E. Spaner, David W. Andrews
Journal: Blood
Blood (2016) 128 (7): 934–947.
https://doi.org/10.1182/blood-2015-12-687814
Published: 2016
Includes: Supplemental data
Journal Articles

Microenvironmental interleukin-6 suppresses toll-like receptor signaling in human leukemia cells through miR-17/19A

Yanmei Li, Yonghong Shi, Lindsay McCaw, You-Jun Li, Fang Zhu, Reg Gorczynski, Gordon S. Duncan, Burton Yang, Yaacov Ben-David, David E. Spaner
Journal: Blood
Blood (2015) 126 (6): 766–778.
https://doi.org/10.1182/blood-2014-12-618678
Published: 2015
Includes: Supplemental data
Journal Articles

PPARα and fatty acid oxidation mediate glucocorticoid resistance in chronic lymphocytic leukemia

Stephanie Tung, Yonghong Shi, Karry Wong, Fang Zhu, Reg Gorczynski, Robert C. Laister, Mark Minden, Anne-Kareen Blechert, Yvonne Genzel, Udo Reichl, David E. Spaner
Journal: Blood
Blood (2013) 122 (6): 969–980.
https://doi.org/10.1182/blood-2013-03-489468
Published: 2013
Includes: Supplemental data
Journal Articles

B-cell depletion and remissions of malignancy along with cytokine-associated toxicity in a clinical trial of anti-CD19 chimeric-antigen-receptor–transduced T cells

Clinical Trials & Observations
James N. Kochenderfer, Mark E. Dudley, Steven A. Feldman, Wyndham H. Wilson, David E. Spaner, Irina Maric, Maryalice Stetler-Stevenson, Giao Q. Phan, Marybeth S. Hughes, Richard M. Sherry, James C. Yang, Udai S. Kammula, Laura Devillier, Robert Carpenter, Debbie-Ann N. Nathan, Richard A. Morgan, Carolyn Laurencot, Steven A. Rosenberg
Journal: Blood
Blood (2012) 119 (12): 2709–2720.
https://doi.org/10.1182/blood-2011-10-384388
Published: 2012
Includes: Supplemental data
Journal Articles

Aberrant interferon-signaling is associated with aggressive chronic lymphocytic leukemia

Jelena Tomic, Brian Lichty, David E. Spaner
Journal: Blood
Blood (2011) 117 (9): 2668–2680.
https://doi.org/10.1182/blood-2010-05-285999
Published: 2011
Includes: Supplemental data
Journal Articles

The inositol phosphatase SHIP-1 is negatively regulated by Fli-1 and its loss accelerates leukemogenesis

Gurpreet K. Lakhanpal, Laura M. Vecchiarelli-Federico, You-Jun Li, Jiu-Wei Cui, Monica L. Bailey, David E. Spaner, Daniel J. Dumont, Dwayne L. Barber, Yaacov Ben-David
Journal: Blood
Blood (2010) 116 (3): 428–436.
https://doi.org/10.1182/blood-2009-10-250217
Published: 2010
Includes: Supplemental data
Journal Articles

Extracellular calcium sensing promotes human B-cell activation and function

Caitlin M. Hammond, Dionne White, Jelena Tomic, Yonghong Shi, David E. Spaner
Journal: Blood
Blood (2007) 110 (12): 3985–3995.
https://doi.org/10.1182/blood-2007-05-088468
Published: 2007
Journal Articles

Rituximab Increases Response to ESHAP in Relapsed, Refractory, and Transformed Aggressive B-Cell Lymphoma.

Lisa Hicks, Rena Buckstein, Joy Mangel, Eugenia Piliotis, Kevin Imrie, Matthew C. Cheung, David E. Spaner, Marciano D. Reis, Zeina Ghorab, Violet Milliken, Nancy Pennell, Neil Berinstein
Journal: Blood
Blood (2006) 108 (11): 3067.
https://doi.org/10.1182/blood.V108.11.3067.3067
Published: 2006